Our Mission Statement
ExsoMed is dedicated to delivering innovative, high-quality technologies and products that will advance the standard of care and revolutionize hand surgery for our patients and surgeons throughout the world.
Our STORY
Good enough is not good enough, especially when it comes to hand surgery. For too long, few good options have led to sub-optimal results that have become the accepted norm. Dissatisfied with the current standard of care in the orthopaedic hand space, veteran hand surgeons Dr. Lloyd Champagne and Dr. Jozef Zoldos set out to transform the way hand surgery is performed today. That pursuit became ExsoMed, a company focused on developing innovative techniques and products purposefully designed to revolutionize hand surgery. Every day, we strive to help our surgeons achieve exceptional outcomes and happier patients. And this commitment has led us to invest heavily in product development, training, and education to advance the standard of care for our patients and surgeons everywhere.
Executive Management
William E. Maya, Chief Executive Officer and Director
Mr. Maya has over 30 years of hands-on operating experience, predominantly in senior management roles. He is a results-driven executive with creative problem solving capabilities, and is extremely adept at identifying, fixing and capitalizing on under-performing business assets/opportunities. As an intuitive, effective leader, he is astute at restructuring operations for growth and profitability and has a strong track record of proven success. Considered a strategist, he has effectively managed change and crises in several troubled situations towards successful outcomes, constantly driving innovation that has delivered strong bottom-line results.
Augmenting his executive level, company building skill set, Mr. Maya has wide-ranging Board and Chairman level experience that has effectively guided/communicated strategic vision to several senior management teams, while building consensus that drove multiple organizations to success. Having significant experience with private equity and venture funds, Mr. Maya’s leadership spans turnaround and rapid growth environments. He has advised and operated both public and private companies in domestic and international markets. Although Mr. Maya’s experience spans several industries, he has particular core strengths and expertise in the life sciences and various healthcare technologies. He also has wide-ranging software industry experience, including the successful completion of a number of purchase and sale transactions.
Jon D. Holder, Chief Revenue Officer
Jon D. Holder serves as ExsoMed’s Chief Revenue Officer, responsible for Sales and Business Development.
Mr. Holder has responsibility for and expertise in sales management, enterprise relationships, strategic partnership creation, deal assessment, due diligence, and organizational development.
Prior to ExsoMed, he held the title of VP, Strategic Business Development for Tenex Corporation, where he had responsibility for reimbursement strategy and enterprise relationships.
Previously, he was Managing General Partner, Holder Capital Partners, working with founders, capital sources and management, in the development of early stage companies. During his tenure, he led the investment in 7 of the 15 investments made by HCP. Among those opportunities were Pyxis (1987), TheraTx (1992), EDiX (1991-98), and MedAssets (2000).
Additionally, Jon has held executive leadership positions in EDiX (1991-98), Holder Family Office (1986 to 2009), Vestara (2009-2011), MagnaFlow (2011-14) and K&N Engineering (2014-15); these last two he combined his passion within the performance automotive aftermarket, with his expertise in running high performance sales and marketing teams.
Mr. Holder has a Bachelor of Arts degree in History with a Business Emphasis from the University of California at Los Angeles (UCLA).
James Young Kim, Chief Marketing Officer and Managing Director, International Sales
James Kim has over 15 years of strategic marketing and sales leadership experience in the medical device and healthcare industry. His diverse commercial assignments have included full P/L management, U.S. and International Sales, strategic planning, product and brand management, product development, KOL management, and multiple global product launches. Prior to joining ExsoMed, James served in key commercial and executive roles with OrthAlign, Allergan, CareFusion, and Johnson & Johnson, successfully growing and managing the KneeAlign®, Natrelle®, Pyxis®, and OneTouch® brands, respectively. James received an MBA from the University of Southern California’s Marshall School of Business.
Daniel Mickelsen, Chief Operating Officer and Chief Financial Officer
Daniel Mickelsen has 28 years of experience in leadership roles spanning the medical device, automotive aftermarket, software development, industrial automation, data visualization, communication, and creative industries. Regardless of market segment, Mr. Mickelsen has proven success in strategic marketing, aggressive growth environments where he champions sustainable scalability, data-driven operational and financial planning and modeling, and market intelligence.
Currently, he is Chief Operating Officer and Chief Financial Officer for ExsoMed, an innovative and rapidly growing Medical Device manufacturer. In this role Mr. Mickelsen is responsible for all R&D, operations, business intelligence, and finance efforts of the company.
Prior to this position, he was Chief Operating Officer at SCS, a full-service advertising and strategic marketing agency. During his tenure, SCS grew by more than 300% and became the most awarded and fastest growing agency in Southern California. Previously, he was Director of Marketing and Consumer Data for Transamerican Auto Parts, the second largest automotive aftermarket company in California. Prior to this, Mr. Mickelsen was Director of Marketing and Data at MagnaFlow, a worldwide leader in the manufacture of catalytic converters and exhaust systems. He was Co-Founder and President of InteliSea, a multi-system automation and data visualization start-up for luxury yachts and ships. Mr. Mickelsen began his entrepreneurial career as Co-Founder and Partner at BrainTrust Media, a boutique firm for brand identity clients such as Coca-Cola and Ericsson.
Mr. Mickelsen received a MFA from University of Alaska Anchorage and BA from UCLA.
Board of Directors
James E. Houlihan III, Chairman of the Board
Mr. Houlihan has been helping to build businesses for more than 25 years through people, strategic development and the application of technology. He has worked with more than 30 company boards of directors providing guidance and expertise on overall strategy, business development, CEO mentoring, acquisition programs, organizational development and executive search coordination and capital structure.
Mr. Houlihan has worked with companies across stages of maturity from pre-revenue start-ups to profitable growth stage businesses. He has experience with numerous industries including healthcare products, services and technology, wireless, software, Internet applications, information technology, distribution and business services.
Mr. Houlihan began his career with Boston Capital Ventures (BCV) a venture capital and growth equity partnership based in Boston. His work at BCV focused primarily on healthcare, software, and business services. Mr. Houlihan came to Southern California in 1994 as a Co-Founder of InnoCal, a multi-stage private investment firm based in Costa Mesa that managed more than $175 million in committed capital.
Currently, Mr. Houlihan serves as an independent director for early stage companies and works with Harvey & Company a leading buy-side advisory firm that conducts strategic acquisition searches for private equity funds and corporations where he leads the technology practice as well as the firm’s co-investment program.
Mr. Houlihan received a BA in Political Science from Middlebury College and an MBA in Finance from the Boston University School of Management.
Tom Curzon, Director
Tom is a veteran venture capital lawyer and partner at Osborn Maledon, P.A., where he co-chairs Osborn Maledon’s business practice. His practice focuses primarily on serving as outside general counsel and trusted and strategic advisor to emerging, growth-oriented companies. He is an active angel investor, having invested in over 25 early stage companies, such as ExsoMed, Armor Defense (FireHost), Defendry, Tonic Health, Hivewyre, Phanto, Leap (Infusionsoft), Calimmune, ReplyBuy, NetPro Computing, Autonet Mobile, Syncardia, Regenesis Biomedical, Post.Bid.Ship, and others. In addition to ExsoMed’s Board, he serves on the Board Managers of Defendry, on the Board of Advisors of the College of Liberal Arts and Sciences at Kansas University, as Chairman of the Board for Startup AZ Foundation, and on the advisory boards for Hivewyre, Phanto and ReplyBuy. Previous advisory board service includes Aural Analytics, EmpowHER, and Iris PR Management.
William E. Maya, Chief Executive Officer and Director
Mr. Maya has over 30 years of hands-on operating experience, predominantly in senior management roles. He is a results-driven executive with creative problem solving capabilities, and is extremely adept at identifying, fixing and capitalizing on under-performing business assets/opportunities. As an intuitive, effective leader, he is astute at restructuring operations for growth and profitability and has a strong track record of proven success. Considered a strategist, he has effectively managed change and crises in several troubled situations towards successful outcomes, constantly driving innovation that has delivered strong bottom-line results.
Augmenting his executive level, company building skill set, Mr. Maya has wide-ranging Board and Chairman level experience that has effectively guided/communicated strategic vision to several senior management teams, while building consensus that drove multiple organizations to success. Having significant experience with private equity and venture funds, Mr. Maya’s leadership spans turnaround and rapid growth environments. He has advised and operated both public and private companies in domestic and international markets. Although Mr. Maya’s experience spans several industries, he has particular core strengths and expertise in the life sciences and various healthcare technologies. He also has wide-ranging software industry experience, including the successful completion of a number of purchase and sale transactions.
Executive Surgeon Council
ExsoMed’s Executive Surgeon Council is an elite group of surgeons dedicated to advancing the standards of care and innovating in hand surgery. The group provides guidance for ExsoMed’s activities in product development, training and education, clinical studies, and presenting to the surgeon community from podium.
Mark Rekant, MD
Thomas Jefferson University School of Medicine
Dr. Rekant completed his undergraduate education Magna Cum Laude at Duke University and Medical School at the University of Medicine and Dentistry of New Jersey – New Jersey Medical School on a full academic scholarship. He completed his Orthopaedic Surgery Residency at New York University Medical Center – NYU Medical School after a general surgery internship. Dr. Rekant fulfilled his specialty training with a Hand and Upper Extremity Surgical Fellowship with Philadelphia Hand to Shoulder Center and Thomas Jefferson University Hospital.
He is currently an Associate Professor in the Department of Orthopaedic Surgery at Thomas Jefferson University and has been with Philadelphia Hand to Shoulder Center since 2001. He proudly delivers specialized orthopaedic care and treatment of both simple and complex ailments of the hands, wrists, elbows, and shoulders.
Dr. Rekant has published numerous peer-reviewed papers in professional medical literature on subjects ranging from general repair techniques and core knowledge to the unique characteristics of various syndromes and injuries in the general population and athletes, in particular. He has presented routinely for over a decade at national and international conferences and symposia.
Marc Richard, MD
Duke University School of Medicine
Dr. Richard completed medical school at the University of Vermont College of Medicine in 2001 and went on to complete his residency in orthopaedic surgery at Boston University Medical Center. In 2006, he began his fellowship in Hand, Upper Extremity, and Microvascular Surgery at Duke University and has stayed there ever since.
Dr. Richard’s research evaluates the clinical outcomes of fractures of the upper extremity, with a particular interest in wrist and elbow fractures and improving ways to treat elbow arthritis in young patients. He has a clinical and research interest in adolescent elbow throwing injuries.
Outside of work, Dr. Richard likes to spend time with his wife and two children, along with run, swim, fly fish and play tennis. He and his family also enjoy following the Boston Red Sox and New England Patriots.
David Shenassa, MD
Sports Medicine Associates of South Florida
Dr. David Shenassa is a fellowship-trained Hand, Wrist, and Microvascular Surgeon. He specializes in reconstructive surgery of the hand and wrist, sports injuries, trauma, nerve compression syndromes, minimally invasive surgical procedures, and wrist arthroscopy.
Dr. Shenassa attended New York University for his undergraduate studies and attended medical school at the prestigious Technion Israel Institute of Technology Faculty of Medicine in Haifa, Israel. After completing his surgical residency in New York at the North Shore-Long Island Jewish Health System, an affiliate of the NYU/Albert Einstein Schools of Medicine, he moved to Los Angeles to complete his sub-specialty training. Dr.Shenassa completed his hand surgery training at the Joseph H. Boyes Hand and Microsurgery Fellowship Program in the Department of Orthopedic Surgery at The University of Southern California, Keck School of Medicine. At USC he worked under an expert team of doctors directly responsible for the care and treatment of the USC Trojans athletic teams.
After completing his training, Dr.Shenassa joined the team of physicians at the South Florida Institute of Sports Medicine as their Hand and wrist specialist. Dr.Shenassa is committed to providing the highest level of care for musculoskeletal and neurovascular conditions of the upper extremity. After an appropriate diagnosis has been made, treatment is geared towards the restoration of function, pain control, and return to pre-injury activity level. He believes in a multidisciplinary approach and always maximizes conservative treatment before considering surgery.
Jeffrey Yao, MD
Stanford University Medical Center
Dr. Jeffrey Yao is Associate Professor, Robert A. Chase Hand and Upper Limb Center in the Department of Orthopaedic Surgery at Stanford University Medical Center.
He completed his medical education at Cornell University Medical College, his residency at Albert Einstein College of Medicine, where he was Orthopaedic Surgery Resident of the Year, and completed his Hand and Upper Extremity Fellowship at the Philadelphia Hand Center, Thomas Jefferson University Hospital.
Dr. Yao’s current research and scholarly interests are focused on minimally invasive and arthroscopic treatment alternatives for common hand and wrist disorders and biologic augmentation of tendon repair strategies utilizing stem cells.
Careers
Thank you very much for your interest in joining our growing ExsoMed family. Please see below any open opportunities by department. Please note, due to the overwhelming number of submissions, ExsoMed will only respond to candidates of interest. Thank you very much.
Openings
Please check back for upcoming positions.